Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date28 Jan 2019 |
100 Clinical Results associated with Qingdao Huaren Tery Pharmaceutical Co. Ltd.
0 Patents (Medical) associated with Qingdao Huaren Tery Pharmaceutical Co. Ltd.
100 Deals associated with Qingdao Huaren Tery Pharmaceutical Co. Ltd.
100 Translational Medicine associated with Qingdao Huaren Tery Pharmaceutical Co. Ltd.